Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860795 · ClinicalTrials.gov registry record · NA
Immunologic Effects of Echinacea
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00860795 is a NA study that has completed, run by University of Washington. The registered enrollment target is 20 participants.
The verdict
NCT00860795, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this study is to determine if Echinacea purpurea stimulates the immune system. For the study, 20 healthy adults will be randomized to receive Echinacea purpurea or placebo for 10 days. Blood will be drawn to assess immune markers just before beginning the study medication, during the 10 day course of medication and after completing the course of medication. It is postulated that adults receiving the Echinacea will have evidence of immune stimulation and those receiving placebo will not.
Interventions
- DRUG placebo
- BIOLOGICAL Echinacea purpurea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00860795
The ClinicalTrials.gov registry entry for NCT00860795 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00860795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00860795 about?
NCT00860795 is a clinical study titled "Immunologic Effects of Echinacea". The goal of this study is to determine if Echinacea purpurea stimulates the immune system. For the study, 20 healthy adults will be randomized to receive Echinacea purpurea or placebo for 10 days. Blood will be drawn to assess immune markers just before beginning the study medication, during the 10 ...
What is the current status of trial NCT00860795?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-03. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00860795?
The interventions under investigation include: placebo (DRUG), Echinacea purpurea (BIOLOGICAL).
Who is sponsoring clinical trial NCT00860795?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.